Clinical Trials Browser

Phase 2 × Neoplasms × Gemcitabine × Clear all

NCT02101775 2026-03-19

Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Active not recruiting

124 enrolled 17 charts

Brenner Tumor, Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT06623656 2025-10-23

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

Phase 2 Recruiting

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT03929666 2025-09-12

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06632951 2025-08-11

LIVIGNO-3

Phase 2 Active not recruiting

Carcinoma, Transitional Cell, Neoplasms

NCT03697564 2025-08-06

Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer

Phase 2 Completed

2 enrolled 10 charts

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT07019220 2025-06-13

COBRA

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT05673811 2025-04-16

VIRAGE

Phase 2 Completed

Neoplasm Metastasis, Neoplasms

NCT02650804 2025-03-26

BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients

Phase 2 Completed

45 enrolled 14 charts

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT06119217 2024-12-04

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

Phase 2 Active not recruiting

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT06696742 2024-11-20

PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma

Phase 2 Recruiting

Neoplasms

NCT03678883 2024-11-07

9-ING-41 in Patients with Advanced Cancers

Phase 2 Active not recruiting

BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT02352337 2024-07-10

PANOPTIMOX

Phase 2 Completed

276 enrolled 12 charts

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00020345 2023-10-31

Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas

Phase 2 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms, Pancreatic Neoplasms

NCT01726582 2023-08-14

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

Phase 2 Completed

229 enrolled 14 charts

Gastrointestinal

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT00394147 2022-08-05

Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer

Phase 2 Terminated

17 enrolled 8 charts

Head and Neck Neoplasms, Neoplasms

NCT02117024 2020-02-05

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Phase 2 Terminated

66 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01088815 2019-04-26

Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas

Phase 2 Completed

98 enrolled 14 charts

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pancreatic Diseases, Pancreatic Neoplasms

NCT01376310 2019-02-19

GSK1120212 Rollover Study

Phase 2 Terminated

159 enrolled 9 charts

Neoplasms

NCT00557492 2018-09-25

Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer

Phase 2 Completed

59 enrolled 13 charts

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT02195180 2018-07-27

Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

Phase 2 Completed

Adenocarcinoma, Neoplasms

NCT02241551 2018-07-26

Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer

Phase 2 Terminated

2 enrolled 7 charts

Neoplasms

NCT00870870 2018-06-01

A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before

Phase 2 Completed

64 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00061308 2017-06-09

Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT01964534 2017-01-31

AFUGEM

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT00336700 2016-09-19

A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer

Phase 2 Terminated

25 enrolled 10 charts

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00588666 2016-01-22

Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

Phase 2 Completed

51 enrolled 7 charts

GenitourinaryMyeloid

Carcinoma, Transitional Cell, Myeloproliferative Disorders, Neoplasms

NCT00983541 2015-08-19

Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma

Phase 2 Terminated

1 enrolled 4 charts

Gastrointestinal

Liver Neoplasms, Neoplasms, Cholangiocarcinoma

NCT00096993 2015-06-10

A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Completed

131 enrolled 11 charts

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00660699 2015-05-27

A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers

Phase 2 Completed

50 enrolled 21 charts

Gastrointestinal

Gallbladder Neoplasms, Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

NCT01472198 2015-03-10

A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Phase 2 Completed

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT01019382 2014-12-04

A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Carcinoma, Neoplasms, Pancreatic Neoplasms

NCT01124786 2014-04-17

A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)

Phase 2 Completed

367 enrolled 10 charts

Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT00247416 2014-03-07

Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer

Phase 2 Completed

60 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00413283 2013-10-24

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

63 enrolled 15 charts

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Thrombocytopenia

NCT01830322 2013-08-14

Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer

Phase 2 Withdrawn

Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT00660140 2013-08-13

Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer

Phase 2 Completed

Gastrointestinal

Gallbladder Neoplasms, Neoplasms, Cholangiocarcinoma

NCT00401570 2013-01-30

A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Carcinoma, Neoplasms, Pancreatic Neoplasms

NCT00837239 2012-07-12

Huachansu & Gemcitabine in Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Gastrointestinal Diseases, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT00673504 2011-12-01

First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00250822 2011-10-05

Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter

Phase 2 Completed

Gastrointestinal

Liver Neoplasms, Neoplasms

NCT00178763 2011-03-03

FR-WB-TT

Phase 2 Unknown

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00276003 2010-01-07

INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.

Phase 2 Completed

Lymphoma, Non-Hodgkin, Neoplasms

NCT00102700 2009-04-29

ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT00005926 2008-03-04

Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas

Phase 2 Completed

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00034606 2006-07-19

Comparing 3 Schedules of Alimta Plus Gemzar

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms